SHEILA MARIANO

Allopathic & Osteopathic Physicians|Internal Medicine JONESBORO, LA NPI 1104896919

General Payments — all program years on this page

$2,029.13

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 117
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $285.47 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $285.4716

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $511.6334
2019 $329.4419
2020 $115.887
2021 $83.905
2022 $372.7120
2023 $330.1016
2024 $285.4716

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087079760 Novartis Pharmaceuticals Corporation $17.27 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096590277 Novo Nordisk Inc $17.12 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097058390 Novo Nordisk Inc $20.96 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097218065 Novo Nordisk Inc $17.94 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097347129 Novo Nordisk Inc $17.83 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097691940 Novo Nordisk Inc $16.76 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104282621 AstraZeneca Pharmaceuticals LP $19.84 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104391033 AstraZeneca Pharmaceuticals LP $17.41 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105270921 AstraZeneca Pharmaceuticals LP $15.51 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105856496 AstraZeneca Pharmaceuticals LP $13.75 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115903395 Amgen Inc. $15.14 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117875479 Boehringer Ingelheim Pharmaceuticals, Inc. $17.07 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124849006 Abbott Laboratories $22.35 02/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135403836 Lilly USA, LLC $18.21 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135416885 Lilly USA, LLC $20.67 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135424615 Lilly USA, LLC $17.64 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.